Compendium of Cancer Genome Aberrations

Leadership

This is a checked version, approved on 19 January 2022. New changes may have been made.

Meet your editors! We welcome questions and your participation in the CCGA.

  • Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; jhodge1@iu.edu; Editor-in-Chief CCGA
    Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; jhodge1@iu.edu; Editor-in-Chief CCGA
  • Kilannin Krysiak, PhD, Assistant Professor, Department of Pathology and Immunology, Washington University School of Medicine; kkrysiak@wustl.edu; Technical Editor CCGA
    Kilannin Krysiak, PhD, Assistant Professor, Department of Pathology and Immunology, Washington University School of Medicine; kkrysiak@wustl.edu; Technical Editor CCGA
  • Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; fabiolaq@hs.uci.edu; Associate Editor CCGA [MDS/MPN Section]
    Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; fabiolaq@hs.uci.edu; Associate Editor CCGA [MDS/MPN Section]
  • Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; YAkkari@LHS.ORG; Associate Editor CCGA [ALL Section]
    Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; YAkkari@LHS.ORG; Associate Editor CCGA [ALL Section]
  • Snehal Patel, MD, PhD; sbpatel2009@gmail.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]
    Snehal Patel, MD, PhD; sbpatel2009@gmail.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]
  • Greg Corboy, PhD, Pathology Queensland (Queensland, Australia) School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); gregcorboy@bigpond.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Hodgkin Lymphomas/Lymphoproliferative Disorders/Other Rare Entities Section]
    Greg Corboy, PhD, Pathology Queensland (Queensland, Australia) School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); gregcorboy@bigpond.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Hodgkin Lymphomas/Lymphoproliferative Disorders/Other Rare Entities Section]
  • Malini Sathanoori, PhD, FACMG, Senior Cytogenetics Director, Quest Diagnostics, Chantilly VA; msathanoori@yahoo.com; Associate Editor CCGA [AML Section]
    Malini Sathanoori, PhD, FACMG, Senior Cytogenetics Director, Quest Diagnostics, Chantilly VA; msathanoori@yahoo.com; Associate Editor CCGA [AML Section]
  • Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; Alanna.Church@childrens.harvard.edu; Associate Editor CCGA [Gene-Specific Section]
    Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; Alanna.Church@childrens.harvard.edu; Associate Editor CCGA [Gene-Specific Section]
Retrieved from "https://test.ccga.io/index.php?title=Leadership&oldid=10997"